Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Marsh (NYSE: MRSH) SEC filings page on Stock Titan is designed to help investors and analysts review the company’s regulatory disclosures in a structured way. While recent SEC filings are not listed in the available data, this page is where users can access Marsh’s future submissions to the US Securities and Exchange Commission once they are posted to EDGAR.
For a company that describes itself as a global leader in risk, reinsurance and capital, people and investments, and management consulting, key filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q can provide important detail on business segments, risk factors, and financial performance. Current reports on Form 8-K may highlight material events, including dividend declarations or other board decisions affecting Marsh’s common stock.
When available, proxy statements and related filings can offer additional information on governance and executive matters, while Form 4 filings can be used to track transactions by directors and certain officers in Marsh’s equity.
Stock Titan enhances these documents with AI-powered summaries that explain the main points of lengthy filings in accessible language. Users can quickly see what has changed from one period to the next, identify notable disclosures, and then drill into the full text for deeper analysis. Real-time updates from EDGAR ensure that new Marsh filings appear promptly, while AI-generated insights help reduce the time required to interpret complex regulatory documents.
Marsh & McLennan Companies entered into a new Amended and Restated 5 Year Credit Agreement providing a multi-currency, unsecured $4.25 billion five-year revolving credit facility. The interest rate is based on Term SOFR plus a fixed margin that varies with the company’s credit ratings.
The new facility expires in June 2031 and requires Marsh & McLennan to maintain specified coverage and leverage ratios that are tested quarterly. In connection with this agreement, the company terminated its prior multi-currency unsecured $3.5 billion five-year revolving credit facility dated October 11, 2023.
Marsh & McLennan Companies President and CEO John Q. Doyle reported an option exercise and related share sale. He exercised options to acquire 16,656 shares of Common Stock at $73.195 per share, then sold 16,656 shares at $161.71 per share in an open‑market transaction.
The filing notes that the sale was effected under a pre‑arranged Rule 10b5‑1 trading plan, meaning it was scheduled in advance. After these transactions, Doyle continues to hold over 100,000 shares of Marsh & McLennan stock directly.
Marsh & McLennan Companies President and CEO John Q. Doyle reported an option exercise and related share sale. He exercised options to acquire 16,656 shares of Common Stock at $73.195 per share, then sold 16,656 shares at $161.71 per share in an open‑market transaction.
The filing notes that the sale was effected under a pre‑arranged Rule 10b5‑1 trading plan, meaning it was scheduled in advance. After these transactions, Doyle continues to hold over 100,000 shares of Marsh & McLennan stock directly.
Marsh & McLennan Companies director Morton O. Schapiro received an annual equity grant of 1,349.82 restricted stock units. The award, made under the Marsh & McLennan Companies Directors Stock Compensation Plan, is valued at a reference price of $159.28 per unit and converts into common stock on a 1-for-1 basis.
Following this grant, Schapiro directly holds 90,445.40 shares of common stock, including the underlying shares from these units. This is a compensation-related award rather than an open-market purchase or sale.
Marsh & McLennan Companies director Morton O. Schapiro received an annual equity grant of 1,349.82 restricted stock units. The award, made under the Marsh & McLennan Companies Directors Stock Compensation Plan, is valued at a reference price of $159.28 per unit and converts into common stock on a 1-for-1 basis.
Following this grant, Schapiro directly holds 90,445.40 shares of common stock, including the underlying shares from these units. This is a compensation-related award rather than an open-market purchase or sale.
Marsh & McLennan Companies director Anthony Anderson received an annual equity grant of 1,349.82 restricted stock units. The award was made under the Marsh & McLennan Companies Directors Stock Compensation Plan and is classified as a grant or award acquisition, not an open-market purchase.
The restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis, aligning the director’s compensation with future share performance. Following this grant, Anderson holds a total of 17,082.15 units directly, reinforcing his equity stake in the company.
Marsh & McLennan Companies director Anthony Anderson received an annual equity grant of 1,349.82 restricted stock units. The award was made under the Marsh & McLennan Companies Directors Stock Compensation Plan and is classified as a grant or award acquisition, not an open-market purchase.
The restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis, aligning the director’s compensation with future share performance. Following this grant, Anderson holds a total of 17,082.15 units directly, reinforcing his equity stake in the company.
Marsh & McLennan Companies director Deborah C. Hopkins received an annual equity grant under the company’s Directors Stock Compensation Plan. She was awarded 1,349.82 restricted stock units that convert into common stock on a 1-for-1 basis, reflecting a reference price of $159.28 per share. Following this grant, she directly holds 21,414.56 shares-equivalent of common stock. This is a compensation-related award, not an open-market purchase or sale.
Marsh & McLennan Companies director Deborah C. Hopkins received an annual equity grant under the company’s Directors Stock Compensation Plan. She was awarded 1,349.82 restricted stock units that convert into common stock on a 1-for-1 basis, reflecting a reference price of $159.28 per share. Following this grant, she directly holds 21,414.56 shares-equivalent of common stock. This is a compensation-related award, not an open-market purchase or sale.
Marsh & McLennan Companies director Tamara Ingram received an annual stock award in the form of 1,349.82 restricted stock units under the company’s Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis.
After this grant, Ingram directly holds 9,086.35 shares-related units, reflecting routine, compensation-based equity rather than an open-market purchase or sale.
Marsh & McLennan Companies director Tamara Ingram received an annual stock award in the form of 1,349.82 restricted stock units under the company’s Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis.
After this grant, Ingram directly holds 9,086.35 shares-related units, reflecting routine, compensation-based equity rather than an open-market purchase or sale.
Marsh & McLennan Companies director Lloyd M. Yates received an annual stock award of restricted stock units. On June 1, 2026, he was granted 1,349.82 restricted stock units under the Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis, bringing his directly held equity-related position reported in this filing to 12,390.99 shares on a converted basis. This is a compensation-related equity grant rather than an open-market share purchase or sale.
Marsh & McLennan Companies director Lloyd M. Yates received an annual stock award of restricted stock units. On June 1, 2026, he was granted 1,349.82 restricted stock units under the Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis, bringing his directly held equity-related position reported in this filing to 12,390.99 shares on a converted basis. This is a compensation-related equity grant rather than an open-market share purchase or sale.
Marsh & McLennan Companies director Jane H. Lute received an equity award through the company’s director stock plan. She was granted 1,349.82 restricted stock units on June 1, 2026, which convert into common stock on a 1-for-1 basis. Following this grant, she holds 8,911.69 derivative shares linked to common stock. The award is classified as a grant or other acquisition, reflecting routine director compensation rather than an open‑market trade.
Marsh & McLennan Companies director Jane H. Lute received an equity award through the company’s director stock plan. She was granted 1,349.82 restricted stock units on June 1, 2026, which convert into common stock on a 1-for-1 basis. Following this grant, she holds 8,911.69 derivative shares linked to common stock. The award is classified as a grant or other acquisition, reflecting routine director compensation rather than an open‑market trade.
Marsh & McLennan Companies director Jan Siegmund received an annual stock award of 1,349.82 restricted stock units on Marsh & McLennan common stock. The units were valued at $159.28 per underlying share and convert into common stock on a 1-for-1 basis.
Following this grant, Siegmund directly holds 2,298.24 restricted stock units linked to Marsh & McLennan common stock. This is a compensation-related award rather than an open-market purchase or sale.
Marsh & McLennan Companies director Jan Siegmund received an annual stock award of 1,349.82 restricted stock units on Marsh & McLennan common stock. The units were valued at $159.28 per underlying share and convert into common stock on a 1-for-1 basis.
Following this grant, Siegmund directly holds 2,298.24 restricted stock units linked to Marsh & McLennan common stock. This is a compensation-related award rather than an open-market purchase or sale.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills reported an annual stock award, not an open‑market trade. He received a grant of 1,349 shares of common stock at $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After this compensation grant, he holds 5,757.75 shares directly and 47,553 shares indirectly through a trust.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills reported an annual stock award, not an open‑market trade. He received a grant of 1,349 shares of common stock at $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After this compensation grant, he holds 5,757.75 shares directly and 47,553 shares indirectly through a trust.